FDA Inspection
Actimus BioSciences Private Ltd.Actimus BioSciences Private Ltd. – FDA Inspection, Feb 22, 2019
Record Details
This FDA Inspection record concerns Actimus BioSciences Private Ltd., with an inspection on February 22, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Melkamu Getie Kebtie (Issuing Officer)
- Sripal R. Mada (Company Rep)
View Company Profile
ID · d73bfa03-cff9-4d15-a1cc-bfb6495a964b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1087025
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Actimus BioSciences Private Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 2, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 14, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Actimus BioSciences Private Ltd.
- FDA Inspection 1232136 - 2024-02-02
- FDA Inspection 1219736 - 2023-09-22
- FDA Inspection 1177347 - 2022-07-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.